Key result
Ivabradine successfully treats inappropriate sinus tachycardia in a pediatric heart transplant patient with graft failure.
Why the study?
Beta-blockers have limited efficacy for inappropriate sinus tachycardia in denervated transplanted hearts, and ivabradine use had not been reported in paediatric heart transplant rejection.
Case Report (n=1)
Ivabradine may be an effective treatment for inappropriate sinus tachycardia in pediatric patients with denervated transplanted hearts experiencing graft failure.
Answers are grounded in this paper and cite their sources.
May support ivabradine in refractory pediatric post-transplant IST; leaves open confirmation in prospective studies.
We encountered a paediatric case of graft failure due to antibody-mediated rejection after heart transplantation in which ivabradine was effective. Inappropriate sinus tachycardia in denervated transplanted hearts is a good indication for ivabradine administration as beta-blockers have a limited efficacy. To our knowledge, this is the first report on the effectiveness of ivabradine in a paediatric heart transplant rejection case.
No takes yet. Share an insight, caveat, or question.
Ogawa et al. (2022) conducted a case report in Graft failure due to antibody-mediated rejection after heart transplantation (n=1). Ivabradine was evaluated on Effectiveness of ivabradine for inappropriate sinus tachycardia. Ivabradine was effectively used to treat inappropriate sinus tachycardia in a 10-year-old patient with graft failure due to antibody-mediated rejection after heart transplantation.
Synapse has enriched 10 related papers. Consider them for comparative context: